First Time Loading...

Repro Med Systems Inc
NASDAQ:KRMD

Watchlist Manager
Repro Med Systems Inc Logo
Repro Med Systems Inc
NASDAQ:KRMD
Watchlist
Price: 2.32 USD -2.52% Market Closed
Updated: May 5, 2024
Section:
 

Wall Street
Price Targets

KRMD Price Targets Summary
Repro Med Systems Inc

Wall Street analysts forecast KRMD stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for KRMD is 3.77 USD with a low forecast of 2.53 USD and a high forecast of 5.25 USD.

KRMD Lowest Forecast
Wall Street Target
2.53 USD
9% Upside
KRMD Average Forecast
Wall Street Target
3.77 USD
63% Upside
KRMD Highest Forecast
Wall Street Target
5.25 USD
126% Upside
Lowest
Price Target
2.53 USD
9% Upside
Average
Price Target
3.77 USD
63% Upside
Highest
Price Target
5.25 USD
126% Upside
Repro Med Systems Inc Competitors:
Price Targets
V
335890
Viol Co Ltd
24% Upside
PHIA
Koninklijke Philips NV
5% Downside
IPD
ImpediMed Ltd
123% Upside
FPH
Fisher & Paykel Healthcare Corporation Ltd
12% Downside
V
335890
Viol Co Ltd
24% Upside
PHIA
Koninklijke Philips NV
5% Downside
IPD
ImpediMed Ltd
123% Upside
FPH
Fisher & Paykel Healthcare Corporation Ltd
12% Downside
TCMD
Tactile Systems Technology Inc
48% Upside
B
206640
Boditech Med Inc
41% Upside
STE
STERIS plc
18% Upside
4543
Terumo Corp
14% Upside

Revenue
Forecast

Revenue Estimate
Repro Med Systems Inc

For the last 5 years the compound annual growth rate for Repro Med Systems Inc's revenue is 10%. The projected CAGR for the next 3 years is 18%.

10%
Past Growth
18%
Estimated Growth
Estimates Accuracy
-2%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Repro Med Systems Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
0%
Average Beat
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Repro Med Systems Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-6%
Average Miss
What are analyst estimates?

See Also

Summary
KRMD intrinsic value, competitors valuation, and company profile.
DCF Valuation
KRMD stock valuation using Discount Cash Flow valuation method.
Relative Valuation
KRMD stock valuation using valuation multiples.
Wall Street Estimates
KRMD price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
KRMD stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is KRMD's stock price target?
Price Target
3.77 USD

According to Wall Street analysts, the average 1-year price target for KRMD is 3.77 USD with a low forecast of 2.53 USD and a high forecast of 5.25 USD.

What is Repro Med Systems Inc's Revenue forecast?
Projected CAGR
18%

For the last 5 years the compound annual growth rate for Repro Med Systems Inc's revenue is 10%. The projected CAGR for the next 3 years is 18%.

ALPHA SPREAD
Join more than 134,300+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.